Jeffrey Bacha - Net Worth and Insider Trading

Jeffrey Bacha Net Worth

The estimated net worth of Jeffrey Bacha is at least $30 dollars as of 2024-11-13. Jeffrey Bacha is the CEO of Kintara Therapeutics Inc and owns about 4 shares of Kintara Therapeutics Inc (KTRA) stock worth over $30. Details can be seen in Jeffrey Bacha's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jeffrey Bacha has not made any transactions after 2017-10-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Jeffrey Bacha

To

Jeffrey Bacha Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jeffrey Bacha owns 2 companies in total, including Kintara Therapeutics Inc (KTRA) , and CalEthos Inc (GEDC) .

Click here to see the complete history of Jeffrey Bacha’s form 4 insider trades.

Insider Ownership Summary of Jeffrey Bacha

Ticker Comapny Transaction Date Type of Owner
KTRA Kintara Therapeutics Inc 2017-12-22 director
GEDC CalEthos Inc 2008-04-03 director

Jeffrey Bacha Latest Holdings Summary

Jeffrey Bacha currently owns a total of 1 stock. Jeffrey Bacha owns 4 shares of Kintara Therapeutics Inc (KTRA) as of October 6, 2017, with a value of $30.

Latest Holdings of Jeffrey Bacha

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
KTRA Kintara Therapeutics Inc 2017-10-06 4 7.54 30

Holding Weightings of Jeffrey Bacha


Jeffrey Bacha Form 4 Trading Tracker

According to the SEC Form 4 filings, Jeffrey Bacha has made a total of 0 transactions in Kintara Therapeutics Inc (KTRA) over the past 5 years. The most-recent trade in Kintara Therapeutics Inc is the acquisition of 1 shares on October 6, 2017, which cost Jeffrey Bacha around $8,700.

Insider Trading History of Jeffrey Bacha

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jeffrey Bacha Trading Performance

GuruFocus tracks the stock performance after each of Jeffrey Bacha's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jeffrey Bacha is -13.57%. GuruFocus also compares Jeffrey Bacha's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jeffrey Bacha within 3 months outperforms 1 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jeffrey Bacha's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jeffrey Bacha

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 5 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -3.33 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -5.14 LIMIT LIMIT LIMIT LIMIT LIMIT

Jeffrey Bacha Ownership Network

Ownership Network List of Jeffrey Bacha

No Data

Ownership Network Relation of Jeffrey Bacha

Insider Network Chart

Jeffrey Bacha Owned Company Details

What does Kintara Therapeutics Inc do?

Who are the key executives at Kintara Therapeutics Inc?

Jeffrey Bacha is the director of Kintara Therapeutics Inc. Other key executives at Kintara Therapeutics Inc include director & President and CEO Robert Hoffman , Chief Financial Officer Anthony Scott Praill , and director & Head of Strategic Partnerships Saiid Zarrabian .

Kintara Therapeutics Inc (KTRA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Kintara Therapeutics Inc (KTRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kintara Therapeutics Inc (KTRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Kintara Therapeutics Inc (KTRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Kintara Therapeutics Inc Insider Transactions

No Available Data

Jeffrey Bacha Mailing Address

Above is the net worth, insider trading, and ownership report for Jeffrey Bacha. You might contact Jeffrey Bacha via mailing address: Suite 3 1545 West 14th Avenue, Vancouver A1 V6j 2j1.